(Formerly known as Central Clinical School)
Significant findings in the lab can often get lost in their conversion to clinical practice and everyday medical treatments. As such, translational research skills have become a significant part of life at Monash’s three metropolitan clinical schools.
 |
| Dr Taya Collyer is first author on a study looking at changes in hospital attendance during the COVID-19 pandemic |
In a first comprehensive study of healthcare-seeking behaviour in the context of (relatively) low COVID-19 burden, team of researchers from the Academic Unit, Medicine, Peninsula Clinical School analysed data from approximately 700,000 hospital presentations to investigate the impact of restrictions to movement on hospital activity in Melbourne over two waves of community transmission (1 March to 20 September 2020).
 |
| L-R: Dr Narelle Cox and Dr Arwel Jones have both won Lung Foundation Australia grants. |
The LFA awarded a total of $876,000 to 13 research grants from the Hope Research Fund in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer.
Read more from Dr Jones and Dr Cox below. See also the LFA news story.
 |
| The underlying pathophysiology of hallucinogen persisting perception disorder (HPPD) is poorly understood. Study |
Recent publications featuring research as notified by PubMed during 24-30 May 2022 from Central Clinical School affiliated researchers in the following departments. The below is not a comprehensive list.
The most recent validated publications for the school and departments can be seen on their publications pages, linked to from the headings below. Otherwise, read down the entry for recent notifications.
 |
by David Wright, Monash University
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is the most common form of motor neuron disease. People with ALS progressively lose the ability to initiate and control muscle movements, including the ability to speak, swallow and breathe.
There is no known cure. But recently, we studied mice and identified a new target in the fight against this devastating disease: the brain’s waste clearance system.
Read the full story on the faculty news feed and see also JAMA invited commentary by Joe Verghese.
 |
| The webinar featured short presentations followed by a panel discussion. L-R: (Top row) David Derby, Lucy Vivash, Tara McDonald; (Bottom row) Juliana Silva, Nadine Andrew, Malcolm Johnson. See video. |
The Community and Researcher Engagement (CaRE) committee hosted a webinar on 18 May 2022, "What we know about the brain and how it changes with dementia", which covered a range of relevant topics and perspectives relating to
dementia, from the perspectives of those affected by the disease,
clinicians, and researchers.
With dementia being one of the leading cause of death and a significant cause of disability in Australia, particularly in older populations, most of us will—at some stage, and in some way—be touched by the disease.
See:
 |
| Professor Wendy Brown consulting with a patient |
It is the first randomised trial of its kind in the world, funded by the NHMRC and led by Professor Peter Choong and Professor Michelle Dowsey from University of Melbourne / St Vincent’s Hospital Melbourne, in collaboration with Monash University’s Professor Wendy Brown and Dr Paul Burton, assessed the efficacy of substantial weight loss induced by bariatric surgery in reducing complication risk after total knee arthroplasty (TKA) in patients with severe obesity and osteoarthritis.
See full faculty story
 |
| L-R: Dr Erica Plummer and Ms Sabrina Salberg |
The Bridging Postdoctoral Fellowships (BPF) support the career development of promising newly-qualified postdoctoral researchers and final year PhD students. They are intended to provide initial support for recent PhD graduates and final year PhD students while they apply for externally-funded fellowships.
